Using heart pump support for complex high-risk procedures
Part of Heart & circulation clinical trials.
This trial is testing whether using a special heart pump (PulseCath iVAC2L) during complex, high-risk angioplasty can help people with very weak hearts. It's for people who need a procedure for complicated coronary artery blockages.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your heart team has agreed that you need a high-risk angioplasty (with or without heart pump support).
- You are stable enough for the procedure (not in cardiogenic shock).
- Your heart's pumping strength is very low (less than 30%, or less than 35% with moderate valve leakage, or less than 40% with severe valve leakage).
- You have a complex blockage in the left main coronary artery or an equivalent serious blockage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (Ventiflow LP) that helps support the heart during a procedure to open blocked coronary arteries (angioplasty or PCI) in people whose hearts are weak. It may help those who are too high risk for bypass surgery.
This study compares two types of temporary heart pumps used during a high-risk angioplasty (a procedure to open blocked heart arteries). It aims to see which one provides better support for patients with weak hearts, potentially leading to safer outcomes.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This trial tests if using a special temporary heart pump during a procedure to open blocked heart arteries is safe and helps people with weak hearts. The pump supports the heart while the doctor works, and the goal is to improve blood flow and heart function.
Hear when a new High-risk PCI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.